Key facts
- LeafWorks’s last known valuation is $12.0M (Feb 2020).
- It has raised $3.1M across 3 recorded rounds; the latest was Seed Round ($700K) in Sep 2025.
- Notable investors include Bonaventure Equity.
- LeafWorks has filed 3 Form Ds with the SEC since 2020, most recently Dec 2024 ($405K sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for LeafWorks
Funding rounds
3 roundsAbout LeafWorks
Provider of botanical deoxyribonucleic acid testing services intended to ensure accurate labeling of products for the cannabis and herbal industries. The company's services include offering medicinal plants to protect the work and grow the market by preventing fraud with plant identification and research and development for cannabis, enabling clients in the cannabis industry to understand and protect their work and grow their businesses.
- Sector
- Healthcare
- HQ
- Sebastopol, CA, United States
- Founded
- 2016
- Employees
- 19
- Website
- leafworks.com/
- Ownership
- Privately Held (backing)
LeafWorks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LeafWorks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LeafWorks in its N-PORT filings yet. We sweep new filings monthly.